Market Overview

Novo Says FDA Delay Due to Huge Size of Data Submitted, FDA Delay on Degludec Doesn't Change Much, Sees No Advisory Committee Based on FDA Talks So Far -Bloomberg

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: BloombergNews FDA

 

Related Articles (NVO)

Around the Web, We're Loving...

Get Benzinga's Newsletters